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Abstract 
Purpose: 
Necrotizing enterocolitis (NEC) is a known complication of gastroschisis with an incidence above the 
expected rate in the neonatal population. While many physicians today are aware of this association, the 
last publication to explore this association in detail and identify possible risk factors of NEC in 
gastroschisis patients was published over twenty years ago. From our large database of patients with 
gastroschisis managed by a single group of pediatric surgeons, we reviewed our experience and the 
recent literature to update what is known about gastroschisis and NEC. 
Methods: 
From 2001 to 2017, a gastroschisis registry was maintained. Data from 218 gastroschisis patients were 
reviewed. Patient demographics and hospital course were reviewed. Patients with confirmed NEC were 
compared to those without NEC. 
Results: 
Two hundred eighteen patients were born with gastroschisis during the time frame of this study. We 
observed a 5% rate (11 of 218) of NEC. Five patients (45%) developed recurring NEC and 4 patients (36%) 
were readmitted for NEC development following initial discharge. Variables associated with NEC included 
low gestational age (P=0.016) and low birth weight (P=0.003). Patients born prior to 37 weeks gestation 
had a 4.8 times greater risk of developing NEC than those born at term. Rates of IUGR were not 
statistically different between NEC and non-NEC patients. The method of delivery (cesarean vs vaginal), 
use of a silo, and form of nutrition were not significantly associated with NEC development. 
Conclusions: 
The overall incidence of NEC has decreased compared to earlier reports. NEC does complicate the 
hospital course for patients, significantly increasing duration of in-hospital treatment. NEC in 
gastroschisis differs in comparison to traditional NEC, presenting later in life. Risk factors identified 
include low gestational age and low birth weight. Avoiding elective preterm deliveries may decrease the 
rate of NEC in gastroschisis. 
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Abstract
Introduction: Necrotizing enterocolitis 
(NEC) is a known complication of 
gastroschisis with an incidence above the 
expected rate in the neonatal population. 
While many physicians today are aware 
of this association, the last publication to 
explore this association in detail and identify 
possible risk factors of NEC in gastroschisis 
patients was published over twenty years 
ago. From our large database of patients 
with gastroschisis, managed by a single 
group of pediatric surgeons, we reviewed our 
experience and the recent literature to update 
what is known about gastroschisis and NEC.
Methods: From 2001 to 2017, a gastroschisis 
registry was maintained. Data from 218 
gastroschisis patients were reviewed. Patient 
demographics and hospital course were 
reviewed. Patients with confirmed NEC were 
compared to those without NEC.
Results: Two hundred eighteen patients were 
born with gastroschisis during the time frame 
of this study. We observed a 5% rate (11 of 
218) of NEC. Five patients (45%) developed 
recurring NEC and 4 patients (36%) were 
readmitted for NEC development following 
initial discharge. Variables associated with 
NEC included low gestational age (P=0.016) 
and low birth weight (P=0.003). Patients born 
prior to 37 weeks gestation had a 4.8 times 
greater risk of developing NEC than those 
born at term. Rates of intrauterine growth 
restriction (IUGR) were not statistically 
different between NEC and non-NEC 
patients. The method of delivery (cesarean vs 
vaginal), use of a silo, and form of nutrition 
were not significantly associated with NEC 
development.
Conclusions: The overall incidence of NEC, 
based on our data, has decreased compared 
to earlier reports. NEC does complicate the 
hospital course for patients, significantly 
increasing duration of in-hospital treatment. 
NEC in gastroschisis differs in comparison to 
traditional NEC, presenting later in life. Risk 
factors identified include low gestational age 
and low birth weight. Avoiding elective pre-
term deliveries may decrease the rate of NEC 
in gastroschisis.
Introduction
Gastroschisis is a congenital right-sided 
paraumbilical defect allowing protrusion 
of intestines and other abdominal viscera 
out of the abdominal cavity, occurring in 
approximately 1 in 4000 live births1 and has 
increased by about 6% every two years for 
reasons unknown.2 Necrotizing enterocolitis 
(NEC) is a bacterial infection of the intestine, 
primarily observed in pre-term and small 
for gestational age (SGA) babies.3 The 
reported rate of necrotizing enterocolitis in 
gastroschisis patients has been quite variable 
in previous studies.4-16 While many physicians 
today are aware of the association of NEC in 
gastroschisis patients, the last publication to 
explore this association in detail and identify 
possible risk factors of NEC in gastroschisis 
patients was published over twenty years 
ago.4 We examined our experience with 
gastroschisis to identify risk factors for 
necrotizing enterocolitis in this patient 
population.
Materials and Methods
Patient Population and Data Collection:
From 2001 to 2017, a gastroschisis registry 
was prospectively maintained at Children’s 
Hospital and Medical Center, the University 
of Nebraska Medical Center, and Creighton 
University Medical Center (Omaha, NE). 
Patient demographics, surgical details, 
postoperative infections and complications, 
and length of stay were reviewed. Patients 
with confirmed NEC were compared to those 
without NEC. This study was approved by the 
University of Nebraska Medical Center- Joint 
Pediatric Institutional Review Board (#445-
09-EP).
Definitions: The diagnosis of necrotizing 
enterocolitis was made using Bell’s 
classification of radiographic and clinical 
findings (Table 1). Clinical findings of NEC 
included abdominal distention, hematochezia, 
and hemodynamic instability. Radiographic 
findings included pneumatosis intestinalis and 
portal venous gas. Prematurity was defined 
as a gestational age less than 37 weeks. 
Intrauterine growth restriction (IUGR) was 
defined as a birth weight at or below the 10th 
percentile for gestational age. 
Table 1.
Modified Bell’s Criteria were utilized to assist with staging NEC in our study.
Stage Systemic signs Abdominal signs Radiographic signs Treatment
IA
Suspected
Temp instability
Apnea
Bradycardia
Lethargy
Gastric retention
Abd distention
Emesis
Heme + stool
Mild ileus
Intestinal dilation
NPO
Abx x3 days
IB
Suspected
Same as IA Grossly bloody stool Same as IA Same as IA
IIA Same as IA Same as IB +
Absent bowel sounds
± abdominal 
tenderness
Intestinal dilation
Ileus
Pneumatosis 
intestinalis
NPO
Abx x 7-10 days
IIB Same as IA + 
Metabolic acidosis
Thrombocytopenia
Same as IIA + 
Abdominal 
tenderness
± abdominal cellulitis 
or RLQ mass
Same as IIA + ascites NPO
Abx x 14 days
IIIA
Intact bowel
Same as IIB +
Hypotension
Bradycardia
Severe apnea
DIC
neutropenia
Same as IIB _
Peritonitis
Abdominal distention
Same as IIB NPO
Abx x 14 days
Fluid resuscitation
Inotropic support
Ventilator therapy
Paracentesis
IIIB
Perforated 
bowel
Same as IIIA Same as IIIA Same as IIIA + 
Pneumoperitoneum
Same as IIIa +
Surgery
1
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Statistical Analysis: Results were expressed 
as mean±SD or median and interquartile 
range as appropriate. Relative risks were also 
assessed. Analysis was performed using the 
Mann-Whitney test for continuous data and 
the Fisher’s exact test for categorical data. 
A p-value of less than 0.05 was considered 
statistically significant.
Results
Two hundred eighteen patients were born 
with gastroschisis during the time frame of 
this study. The average gestational age was 
35.7 weeks with the average birth weight of 
2455 grams. One hundred forty-six (67%) 
were born via cesarean section. Thirty-three 
percent (71 of 218) of patients were carried 
to term with the remaining patients delivered 
prior to 37 weeks gestation. Patients were kept 
on the ventilator for an average of 5.6 days 
(median=2). Silos were used on 45% (98 of 
218) of patients for an average of 7.2 days. 
The average length of stay was 55.2 days 
(median=36.5) (Table 2).
We observed a 5% rate (11 of 218) of 
NEC. Five patients (45% of NEC patients) 
developed recurring NEC and 4 patients 
(36% of NEC patients) were re-admitted for 
NEC development following initial discharge 
(Tables 3 & 4). Variables associated with 
NEC included low gestational age (34.3 
weeks vs 35.8 weeks, P=0.016) and low 
birth weight (P=0.003). Patients born prior 
to 37 weeks gestation had a 4.8 times greater 
risk of developing NEC than those born at 
term. Rates of IUGR were not statistically 
different between NEC and non-NEC 
patients. The method of delivery (cesarean vs 
vaginal), use of a silo, and form of nutrition 
were not significantly associated with NEC 
development. NEC developed on a median 
of 65 days of life. Infants who developed 
NEC stayed a median of 69 days longer than 
patients who did not develop NEC (104 days 
vs 35 days, P=0.014) (Tables 3 & 4).
Discussion
The incidence of gastroschisis is roughly 1 
in 4,000 live births and appears to increase 
with a 6% rise every two years for reasons 
unknown.1,2,17-21 Worldwide, the survival 
rate of infants born with gastroschisis has 
also improved greatly.22,23 One of the known 
complications of gastroschisis is necrotizing 
enterocolitis. Although numerous reports of 
gastroschisis have identified the rate of NEC 
in gastroschisis, the last series to discuss this 
complication in detail was published over 
twenty years ago.1-2,4-6,9,11-16,24. From our series 
of patients with gastroschisis, we reviewed 
our experience and the recent literature to 
update what is known about gastroschisis and 
NEC.
NEC is primarily a disease of very low birth 
weight, pre-term infants, affecting 10% of 
infants born weighing less than 1500 grams 
and resulting in high rates of morbidity and 
mortality in neonatal intensive care units.12,25 
Traditional NEC occurs by the second or third 
week of life.26-28 NEC in gastroschisis presents 
less traditionally. Gastroschisis patients 
were diagnosed with NEC much later, with 
a median day of diagnosis of 65 days of life. 
Additionally, patients that developed NEC 
generally weighed more than 1500 grams. 
Necrotizing enterocolitis is typically treated 
with gut rest, antibiotics, and, if needed, 
surgery. Similar methods of treatment were 
seen in our NEC patients.
Among our NEC patients, only one (9%) 
required surgical intervention. Our high 
rate of successful conservative management 
is unique in comparison to the general 
neonatal NEC population, which typically 
requires much higher rates of surgical 
intervention.26-28 Fullerton et al observed a 
24% (49 of 204) rate of surgical intervention 
among gastroschisis patients with NEC12. 
Fullerton et al identified a higher mortality 
rate among surgical NEC patients compared 
to those conservatively managed (12.2% vs 
3.9%). These findings suggest a different, less 
severe clinical course of NEC in gastroschisis 
compared to NEC among very low birth 
weight neonates. Fullerton et al suggested 
this fact supports the view that NEC is an 
“umbrella diagnosis” representing variant 
underlying pathologies, stating prevention 
and treatment must be tailored on a patient-
to-patient basis. Our study also experienced 
only one mortality, unlike the high mortality 
Table 3.
Gastroschisis patients who developed necrotizing enterocolitis were compared to gastroschisis 
patients who did not develop necrotizing enterocolitis and data were compared using the Mann-
Whitney test for continuous data and the Fisher’s Exact test for categorical data.
NEC Group n=11 Non-NEC Group n=207 P
Sex 0.352
 Male 8 (73%) 112 (54%)
 Female 3 (27%) 95 (46%)
Gestational age 34.3 ± 2.00 weeks 35.8 weeks 0.016
Birth weight 1955 ± 299.0g (1451 to 2435g)
2479 ± 422.2g 
(1120 to 4200) 0.003
IUGR 4 (36%) 36 (17.4%) 0.121
Delivery Method 1.000
 Cesarean Section 7 (64%) 138 (67%)
 Vaginal Delivery 4 (36%) 69 (33%)
Spontaneous Labor 36% Yes 46% Yes 0.758
Carried to term 0.108
 Yes 1 (9%) 70 (34%)
 No 10 (91%) 137 (66%)
Silo 0.228
 Yes 7 (64%) 91 (44%)
 No 4 (36%) 116 (56%)
 Mean Length
 Range 
5.9 ± 2.0 days 
(2-8 days)
7.3 ± 3.1 days 
(3-15d) 0.130
Ventilator Days 2 (Q1, Q3= 2, 6) 2 (Q1, Q3= 1, 6) 0.544
Length of Stay 104 days (Q1, Q3= 56, 114) 35 days (Q1, Q3= 26, 56) 0.014
Table 2.
Demographics of the total patient population 
identify an average population of late pre-term 
infants with a higher-than-normal rate of IUGR.
N=218 Mean ±SD or number (%) 
or range
 Sex 55% Male
45% Female
 Gestational age
 Carried to term
 Spontaneous labor
35.69± 2.00 weeks 
Range: 28-40weeks
32.6% 
46% 
 Birth weight 2455.0 ± 531.8g 
Range: 1120-4200g
 IUGR Rate 18.4% IUGR
 Type of delivery 67% Cesarean 
33% Vaginal
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Table 4.
Data on demographics and management of each patient who later developed necrotizing enterocolitis area included below.
Demographics Diagnosis and Treatment
EGA 
(weeks)
Birth 
Weight  
(g)
Silo?
DOL  
Diagnosed  
(days)
Post  
Closure  
Day
LOS 
(days) How diagnosed
Bell’s 
Stage
Antibiotics 
Prescribed
Length 
Antibiotics 
Prescribed
Surgery
1 35 2160 Yes 94 88 80
Bloody stool
Pneumatosis
Temp. instability
Bradycardia
Dilated bowel loops
II a
Ampicillin, 
Gentamicin, 
Flagyl
8d
2 32 1780 Yes 63 58 54
Pneumatosis
Distended bowel
Portal Air
Bloody stool
Abdominal distension
II a
Ampicillin, 
Gentamicin, 
Clendamycin
8d
3 36 1724 Yes 54 & 75 47 & 68 114
Pneumatosis
Distended bowel
Portal Air
Ascites
III a
Zosyn, 
Gentamicin
Gentamicin, 
Zosyn, Flagyl
10d
10 d
4 37 2435 No 40 40 114
Abdominal distension
Portal venous gas
Fluid collection
III a
Vancomycin, 
Gentamicin, 
Zosyn
14d, 11d, 
14d Yes
5 36 2160 Yes 69 & 87 61 & 79 145
Pneumatosis
Bloody stool
Distended Bowel
II a
Zosyn
Zosyn, 
Gentamicin, 
Flagyl
7d
7d, 7d, 
7+10 d
6 35 2255 No 73 73 25
Pneumatosis
Bloody stool
Intestinal ischemia
II a
Ampicillin, 
Gentamicin, 
Flagyl
14d
7 31 1451 Yes 15 13 199
Pneumatosis
Temp. instability
Loose stool
Lethargy
II b
Gentamicin, 
Zosyn, 
Vancomycin
21d, 3d, 9d
8 34 1990 Yes 42, 62, & 76
35, 55, 
& 69 104
Pneumatosis
Temp. instability
Lethargy
Abdominal distension
Bilious emesis
II a
Zosyn
Vancomycin, 
Zosyn
11d
7d
9 36 2390 Yes 65 & 79 59 & 73 107
Feeding intolerance
Pneumatosis
Bloody stool
II a Zosyn 10d, 7d
10 31 1700 No 52 & 76 52 & 76 36
Pneumatosis
Abdominal distension
Hematochezia
II a FlagylZosyn
7d
10d
11 34 1900 No 41 41 58
Pneumatosis
Temp. instability
Lethargy
II a ZosynVancomycin 7d
Mean  34  1990  62.5  58.1 89.8
rate seen in pre-term infants with NEC and 
gastroschisis in prior studies.8
The last study to explore the association 
of NEC and gastroschisis in detail was 
Oldham’s study, published over 20 years 
ago.4 Compared to his study, we experienced 
a relatively low rate of NEC (18.5% vs 5%, 
10/54 vs 11/218, respectively). An additional 
13 patients in the former study had soft signs 
of NEC, making the difference even greater. 
Mortality in Oldham’s series was 20% overall 
compared to the single death in our series. 
These differences are likely due to advances 
in perinatal, neonatal, and surgical care of this 
complicated patient population. Further, our 
current series carefully reviewed each NEC 
case and assigned a Bell’s stage to ensure the 
accuracy of diagnosis. Our rate of NEC in 
this study was comparable to that rate found 
in several more recent studies, ranging from 
0-15%5-16 (Table 5).
Patients in Oldham’s study were diagnosed 
with NEC on an average of 52 days of life, 
comparable to our study (62.5 days, median 
65 days). Both studies documented that 
patients were readmitted due to development 
of NEC (Oldham: 3/10, Current Study: 4/11). 
Fifty-four percent (29 of 54) of patients 
in Oldham’s study vs. 55% (120/218) in 
our study underwent primary closures of 
their abdominal wall defect. Both reported 
recurring NEC (Oldham: 38%, Current Study: 
45%).4
Lao et al looked at 2490 gastroschisis patients, 
with a NEC rate of 5%, which is comparable 
to our experience (5%).4 The median length of 
stay in Lao’s study was 35 days, as opposed 
to our 104 day median length of stay. Forty 
percent of NEC patients were born prior to 
37 weeks gestation in Lao’s study, while the 
number climbed to 91% in our study. Lao 
et al identified potential modifiable factors 
3
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impacting mortality to include large bowel 
resection and the presence of bacterial sepsis, 
both factors associated with NEC. The clinical 
impact of NEC is consistent in both studies, 
emphasizing the importance of identifying 
modifiable factors to reduce the incidence of 
NEC.
Older reports of gastroschisis have suggested 
early delivery may be associated with better 
outcomes.29-31 This remains controversial. 
More recent studies show worse outcomes 
with early delivery, including an increased 
risk of infectious complications32 and poorer 
long-term neurodevelopmental outcomes.33 
Maramreddy et al found gastroschisis patients 
delivered prior to 37 weeks gestation had 
a 14 times greater risk of morbidities than 
patients carried to term.6 Soares et al also did 
not support pre-term delivery of fetuses with 
gastroschisis, finding no benefit to achieving 
full feeds faster.1 Huang et al found that 
gastroschisis pregnancies carried to term led 
to earlier defect closures, and shorter times 
to full feeds, suggesting that the benefits 
of early delivery cannot be substantiated.34 
Gorra et al found that pre-term gastroschisis 
patients experienced poorer developmental 
outcomes.33 Pre-term, low birth weight infants 
have been identified as being at increased 
risk of infection.32 Patients who developed 
NEC were on average 1.5 weeks younger at 
birth and weighed 484 grams less. Infants not 
carried to term were found to be 4.8 times 
more likely to develop NEC than infants 
carried to term. This raises concern about an 
increased risk of NEC with scheduled pre-
term delivery of patients with gastroschisis.
Prior publications have identified the 
protective nature of human breast milk 
against late onset sepsis, NEC, and death.9,35-36 
The etiology of this may be associated with 
more swift weight gain and reduced feeding 
intolerance associated with breastfed infants. 
Unlike these studies, our study found no 
statistically significant difference in the rate 
of NEC due to form of nutrition. The practice 
of initiating trophic feeds within the first 72 
hours may also promote digestive tolerance, 
allowing faster volume increases and helps the 
neonate achieve full feeds earlier.37
The gastroschisis patients whom develop 
NEC tend to have a much more complicated 
medical course, resulting in a longer length 
of stay on average. NEC can also occur after 
discharge home, requiring readmission of 4 of 
our patients. Because NEC presents itself very 
differently in the gastroschisis population as 
compared to the general neonatal population, 
it is vital for neonatologists, surgeons, and 
general pediatricians to remain vigilant to 
the possibility of acute illness outside of the 
setting of a patient’s initial hospitalization for 
gastroschisis repair. For those gastroschisis 
patients who do experience NEC as a 
complication, conservative management is 
more frequently successful as compared to 
NEC in the general neonatal population
Conclusion 
The overall incidence of NEC has decreased 
compared to earlier reports. NEC does 
complicate the hospital course for patients, 
significantly increasing duration of in-hospital 
treatment. NEC in gastroschisis differs in 
comparison to traditional NEC, by presenting 
later in life. Risk factors identified for NEC in 
gastroschisis include low gestational age and 
low birth weight. Avoiding elective pre-term 
deliveries may decrease the rate of NEC in 
gastroschisis.  
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